Nomura Holdings »

Celldex Therapeutics shares owned by Nomura Holdings

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Nomura Holdings from 13F filings

Historical chart of Nomura Holdings investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Nomura Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Nomura Holdings

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.8M 48k 37.21

More positions owned by Nomura Holdings

Micron Technology (MU)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation (NVDA)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Meta Platforms Cl A (META)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Alibaba Group Hldg Note 0.500% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Honeywell International (HON)
Cadence Design Systems (CDNS)
Pepsi (PEP)
Alphabet Cap Stk Cl C (GOOG)

View all positions for Nomura Holdings

Top funds holding Celldex Therapeutics

Wellington Management Company
BlackRock
Kynam Capital Management
FMR
Vanguard Capital Management
Deep Track Capital
State Street Corporation
Logos Global Management
T. Rowe Price Associates
Geode Capital Management
Eversept Partners
Goldman Sachs Group
Commodore Capital
Bellevue Group
Baker Bros. Advisors

View all funds holding Celldex Therapeutics